News

Recent News About Hesperos and Human-on-a-Chip Technology

Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response following tissue damage and acute inflammation

By Hesperos | June 2, 2020 | Comments Off on Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response following tissue damage and acute inflammation

— New publication in Advanced Science validates potential use in evaluating certain immune responses in drug discovery and systemic diseases, including Coronavirus Disease 2019 (COVID-19)— — Hesperos’ immune system-on-a-chip features recirculating immune cells with the key … Read More

Hesperos Human-on-a-Chip® system used to model preclinical stages of Alzheimer’s disease and mild cognitive impairment

By Hesperos | May 28, 2020 | Comments Off on Hesperos Human-on-a-Chip® system used to model preclinical stages of Alzheimer’s disease and mild cognitive impairment

— Peer-reviewed publication in Alzheimer’s & Dementia: Translational Research & Clinical Interventions validates potential of drug discovery platform and ability to study early stages of disease pathology — ORLANDO, Fla. – May 28, 2020 – Hesperos … Read More

Discussion of Human-on-a-chip for Rare Diseases

By Hesperos | November 30, 2019 | Comments Off on Discussion of Human-on-a-chip for Rare Diseases

In our latest publication, UCF & Hesperos researchers discuss how Human-on-a-chip systems can be used to address the unique challenges facing rare diseases. Researchers cite that rare diseases are “limited by the high cost of research … Read More

HESPEROS TECHNOLOGY FEATURED ON NIH DIRECTOR’S BLOG: BODY-ON-A-CHIP DEVICE PREDICTS CANCER DRUG RESPONSES

By Hesperos | September 30, 2019 | Comments Off on HESPEROS TECHNOLOGY FEATURED ON NIH DIRECTOR’S BLOG: BODY-ON-A-CHIP DEVICE PREDICTS CANCER DRUG RESPONSES

We are proud to announce our latest papers has been featured on the director’s blog of the The National Institutes of Health. In the post, Dr. Francis Collins discusses a study in which Hesperos created a … Read More

Hesperos Human-on-a-Chip Technology Awarded First Phase of $3.8 Million Milestone-based NIH Grant to Study Opiate Overdoses in Collaboration With UCF

By Hesperos | September 26, 2019 | Comments Off on Hesperos Human-on-a-Chip Technology Awarded First Phase of $3.8 Million Milestone-based NIH Grant to Study Opiate Overdoses in Collaboration With UCF

Hesperos, Inc., (www.hesperosinc.com) announced today the University of Central Florida (UCF) received the first phase of a $3.8 million milestone-based National Institutes of Health (NIH) grant for research involving the company’s human-on-a-chip system. “We are grateful … Read More

First Time Human-on-a-Chip Predicts In Vivo Results Based on In Vitro Model

By Hesperos | July 3, 2019 | Comments Off on First Time Human-on-a-Chip Predicts In Vivo Results Based on In Vitro Model

Hesperos’ integrated heart-liver Human-on-a-Chip® shown to correctly determine cardiotoxic mechanisms preclinically and replicate results seen in in vivo studies (ORLANDO, Fla.) — Hesperos Inc., pioneers of the “human-on-a-chip” in vitro system has announced the use of its innovative multi-organ model to successfully measure the … Read More

Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity to Enable Determination of Therapeutic Index

By Hesperos | June 19, 2019 | Comments Off on Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity to Enable Determination of Therapeutic Index

In vitro multi-organ system by Hesperos, Inc. realistically replicates the responses of cancer treatments and has potential to inform treatment decisions. ORLANDO, FLA – June 19, 2019 — A reconfigurable “body-on-a-chip” model could transform drug development … Read More